Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
NCT ID: NCT00362479
Last Updated: 2013-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
1347 participants
INTERVENTIONAL
2006-08-31
2007-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
DR-1021
1 tablet daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DR-1021
1 tablet daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not pregnant or breastfeeding
* Sexually active at risk of pregnancy
Exclusion Criteria
* Pregnancy within the last 3 months
* Smoking \> 10 cigarettes per day
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duramed Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Duramed Research, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Duramed Medical Monitor
Role: PRINCIPAL_INVESTIGATOR
Duramed Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duramed Investigational Site
Huntsville, Alabama, United States
Duramed Investigational Site
Mobile, Alabama, United States
Duramed Investigational Site
Phoenix, Arizona, United States
Duramed Investigational Site
Phoenix, Arizona, United States
Duramed Investigational Site
Carmichael, California, United States
Duramed Investigational Site
Irvine, California, United States
Duramed Investigational Site
San Diego, California, United States
Duramed Investigational Site
San Diego, California, United States
Duramed Investigational Site
San Ramon, California, United States
Duramed Investigational Site
Colorado Springs, Colorado, United States
Duramed Investigational Site
Lakewood, Colorado, United States
Duramed Investigational Site
Wilmington, Delaware, United States
Duramed Investigational Site
Washington D.C., District of Columbia, United States
Duramed Investigational Site
Aventura, Florida, United States
Duramed Investigational Site
Boynton Beach, Florida, United States
Duramed Investigational Site
Brooksville, Florida, United States
Duramed Investigational Site
Clearwater, Florida, United States
Duramed Investigational Site
Coral Gables, Florida, United States
Duramed Investigational Site
Fort Meyers, Florida, United States
Duramed Investigational Site
Leesburg, Florida, United States
Duramed Investigational Site
Longwood, Florida, United States
Duramed Investigational Site
Miami, Florida, United States
Duramed Investigational Site
Pinellas Park, Florida, United States
Duramed Investigational Site
Sarasota, Florida, United States
Duramed Investigational Site
St. Petersburg, Florida, United States
Duramed Investigational Site
St. Petersburg, Florida, United States
Duramed Investigational Site
Tampa, Florida, United States
Duramed Investigational Site
West Palm Beach, Florida, United States
Duramed Investigational Site
Atlanta, Georgia, United States
Duramed Investigational Site
Atlanta, Georgia, United States
Duramed Investigational Site
Decatur, Georgia, United States
Duramed Investigational Site
Roswell, Georgia, United States
Duramed Investigational Site
Boise, Idaho, United States
Duramed Investigational Site
Chicago, Illinois, United States
Duramed Investigational Site
Chicago, Illinois, United States
Duramed Investigational Site
Peoria, Illinois, United States
Duramed Investigational Site
Shawnee Mission, Kansas, United States
Duramed Investigational Site
Topeka, Kansas, United States
Duramed Investigational Site
Lexington, Kentucky, United States
Duramed Investigational Site
Louisville, Kentucky, United States
Duramed Investigational Site
Mount Sterling, Kentucky, United States
Duramed Investigational Site
Kansas City, Missouri, United States
Duramed Investigational Site
Lincoln, Nebraska, United States
Duramed Investigational Site
Las Vegas, Nevada, United States
Duramed Investigational Site
Moorestown, New Jersey, United States
Duramed Investigational Site
New Brunswick, New Jersey, United States
Duramed Investigational Site
Albuquerque, New Mexico, United States
Duramed Investigational Site
Johnson City, New York, United States
Duramed Investigational Site
Rochester, New York, United States
Duramed Investigational Site
Charlotte, North Carolina, United States
Duramed Investigational Site
Raleigh, North Carolina, United States
Duramed Investigational Site
Wilmington, North Carolina, United States
Duramed Investigational Site
Winston-Salem, North Carolina, United States
Duramed Investigational Site
Columbus, Ohio, United States
Duramed Investigational Site
Columbus, Ohio, United States
Duramed Investigational Site
Oklahoma City, Oklahoma, United States
Duramed Investigational Site
Medford, Oregon, United States
Duramed Investigational Site
Philadelphia, Pennsylvania, United States
Duramed Investigational Site
Reading, Pennsylvania, United States
Duramed Investigational Site
Cranston, Rhode Island, United States
Duramed Investigational Site
Greer, South Carolina, United States
Duramed Investigational Site
Mt. Pleasant, South Carolina, United States
Duramed Investigational Site
Bristol, Tennessee, United States
Duramed Investigational Site
Chattanooga, Tennessee, United States
Duramed Investigational Site
Clarksville, Tennessee, United States
Duramed Investigational Site
Germantown, Tennessee, United States
Duramed Investigational Site
Knoxville, Tennessee, United States
Duramed Investigational Site
Nashville, Tennessee, United States
Duramed Investigational Site
Austin, Texas, United States
Duramed Investigational Site
Dallas, Texas, United States
Duramed Investigational Site
Houston, Texas, United States
Duramed Investigational Site
San Antonio, Texas, United States
Duramed Investigational Site
Waco, Texas, United States
Duramed Investigational Site
Magna, Utah, United States
Duramed Investigational Site
Pleasant Grove, Utah, United States
Duramed Investigational Site
Salt Lake City, Utah, United States
Duramed Investigational Site
Sandy City, Utah, United States
Duramed Investigational Site
Arlington, Virginia, United States
Duramed Investigational Site
Newport News, Virginia, United States
Duramed Investigational Site
Norfolk, Virginia, United States
Duramed Investigational Site
Richmond, Virginia, United States
Duramed Investigational Site
Lakewood, Washington, United States
Duramed Investigational Site
Seattle, Washington, United States
Duramed Investigational Site
Spokane, Washington, United States
Duramed Investigational Site
Tacoma, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DR-DSG-301
Identifier Type: -
Identifier Source: org_study_id